Table 1. Patient data for the dual and triple therapy cohorts.

	Dual therapy cohort	Triple therapy cohort
Subjects	72	89
SVR	45 (62.5%)	46 (51.7%)
Sex
Male	51 (71%)	59 (66%)
Female	21 (29%)	30 (34%)
HCV gt1 subtype
a	57 (79.2%)	70 (78.7%)
b	14 (19.4%)	17 (19.1%)
c	1 (1.4%)	nd
Viral load
Median	1,900,000	24,562
Range	3,400–69,000,000	4,990–9,930,000
Fibroscan scores
n	19	71
Liver median (range)	6.8 (3.7–27)	13.9 (4.2–75)
Biopsy scores
Fibrosis, n	49	85
0	1	1
1	12	9
2	16	13
3	15	17
4	5	45

Abbreviations: SVR, sustained virological response; nd, no data.